Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
on air now
Advertisement
Advertisement
Advertisement

AdAlta: A big development for fibrosis sufferers … and it could be lucrative too

Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers. 

BULLS N' BEARS
Advertisement